Cargando…

Mechanical Disruption of Tumors by Iron Particles and Magnetic Field Application Results in Increased Anti-Tumor Immune Responses

The primary tumor represents a potential source of antigens for priming immune responses for disseminated disease. Current means of debulking tumors involves the use of cytoreductive conditioning that impairs immune cells or removal by surgery. We hypothesized that activation of the immune system co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouchlaka, Myriam N., Sckisel, Gail D., Wilkins, Danice, Maverakis, Emanual, Monjazeb, Arta M., Fung, Maxwell, Welniak, Lisbeth, Redelman, Doug, Fuchs, Alan, Evrensel, Cahit A., Murphy, William J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485005/ https://www.ncbi.nlm.nih.gov/pubmed/23133545 http://dx.doi.org/10.1371/journal.pone.0048049

Ejemplares similares

Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy
por: Bouchlaka, Myriam N., et al.
Publicado: (2013)

Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells
por: Grossenbacher, Steven K, et al.
Publicado: (2013)

Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
por: Monjazeb, Arta Monir, et al.
Publicado: (2013)

Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice
por: Mirsoian, Annie, et al.
Publicado: (2014)

Mechanisms by Which Obesity Promotes Acute Graft-Versus-Host Disease in Mice
por: Khuat, Lam T., et al.
Publicado: (2021)

Combined radiotherapy and immunotherapy using CPG oligodeoxynucleotides and indolamine 2,3 dioxygenase (IDO) blockade
por: Monjazeb, Arta M, et al.
Publicado: (2013)

Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
por: Kim, Byungsoo, et al.
Publicado: (2019)

Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+ T Cell Help
por: Monjazeb, Arta M., et al.
Publicado: (2014)

Blocking indolamine 2,3 dioxygenase mediated rebound immune suppression improves systemic anti-tumor effects of radio-immunotherapy
por: Monjazeb, Arta M, et al.
Publicado: (2015)

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
por: Naik, Adviti, et al.
Publicado: (2019)

Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapy
por: Sckisel, Gail D., et al.
Publicado: (2017)

Impact of aging in cancer immunotherapy: The importance of using accurate preclinical models
por: Bouchlaka, Myriam N, et al.
Publicado: (2013)

Red Light Phototherapy Using Light-Emitting Diodes Inhibits Melanoma Proliferation and Alters Tumor Microenvironments
por: Austin, Evan, et al.
Publicado: (2022)

Specificity may be overrated in cancer immunotherapy: Getting to know the nonspecific side of memory T Cells
por: Sckisel, Gail D., et al.
Publicado: (2012)

T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
por: Sparger, Ellen E., et al.
Publicado: (2021)

Urogynecologic complications in Stevens-Johnson syndrome and toxic epidermal necrolysis: Presentation of a case and recommendations for management
por: Petukhova, Tatyana A., et al.
Publicado: (2016)

A proximity labeling method for protein–protein interactions on cell membrane
por: Li, Qiongyu, et al.
Publicado: (2022)

MRI Radiomics for Prediction of Tumor Response and Downstaging in Rectal Cancer Patients after Preoperative Chemoradiation
por: Chen, Haihui, et al.
Publicado: (2020)

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade
por: Wang, Ziming, et al.
Publicado: (2018)

Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream
por: Leventhal, Jonathan S., et al.
Publicado: (2016)

Combined Immune Checkpoint Blockade and Stereotactic Ablative Radiotherapy Can Stimulate Response to Immunotherapy in Metastatic Melanoma: A Case Report
por: Moran, Angel, et al.
Publicado: (2019)

Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era”
por: Lang, Claudia Cécile Valérie, et al.
Publicado: (2021)

T Cell Receptor Complementarity Determining Region 3 Length Analysis Reveals the Absence of a Characteristic Public T Cell Repertoire in Neonatal Tolerance: The Response in the “Tolerant” Mouse within the Residual Repertoire Is Quantitatively Similar but Qualitatively Different
por: Maverakis, Emanual, et al.
Publicado: (2000)

Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review
por: Kim, Byung-Soo, et al.
Publicado: (2020)

Mouse Preclinical Cancer Immunotherapy Modeling Involving Anti-PD-1 Therapies Reveals the Need to Use Mouse Reagents to Mirror Clinical Paradigms
por: Monjazeb, Arta M., et al.
Publicado: (2021)

Anthropomorphic Phantoms for Confirmation of Linear Accelerator-Based Small Animal Irradiation
por: Perks, Julian R, et al.
Publicado: (2015)

Monoclonal antibody therapies targeting immune checkpoints induce fatal anaphylactic reactions in a murine model of breast cancer
por: Mall, Christine, et al.
Publicado: (2014)

Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
por: Monjazeb, Arta M., et al.
Publicado: (2023)

Sentinel Lymph Node Biopsy in Patients with Thick Primary Cutaneous Melanoma: Patterns of Use and Underuse Utilizing a Population-Based Model
por: Martinez, Steve R., et al.
Publicado: (2013)

Exuberant scale crust of the scalp
por: Kao, Jason, et al.
Publicado: (2018)

Distinct immune signatures in directly treated and distant tumors result from TLR adjuvants and focal ablation
por: Chavez, Michael, et al.
Publicado: (2018)

Enhanced natural killer cell targeting of cancer stem cells using Cetuximab
por: Grossenbacher, Steven K, et al.
Publicado: (2014)

BIOLOGICAL THERAPY OF PSORIASIS
por: Sivamani, Raja K, et al.
Publicado: (2010)

No Causal Link between Phosphodiesterase Type 5 Inhibition and Melanoma
por: Wang, Jenny Z., et al.
Publicado: (2019)

Soluble CD40L activates soluble and cell-surface integrin αvβ3, α5β1, and α4β1 by binding to the allosteric ligand-binding site (site 2)
por: Takada, Yoko K., et al.
Publicado: (2021)

Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages
por: Shimoda, Michiko, et al.
Publicado: (2023)

Transcriptome Analysis of Tumor-Infiltrating Lymphocytes Identifies NK Cell Gene Signatures Associated With Lymphocyte Infiltration and Survival in Soft Tissue Sarcomas
por: Judge, Sean J., et al.
Publicado: (2022)

Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity
por: Shen, Shanling, et al.
Publicado: (2020)

Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer
por: Judge, Sean J., et al.
Publicado: (2020)

Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial
por: Wilken, Reason, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n6v0g8a6ucs4eroq83cp7904c3